Frederick Health, a leading healthcare system headquartered in Frederick County, Maryland, has chosen GenomOncology’s Precision Oncology Platform, seamlessly integrated through the industry-leading MEDITECH Expanse Genomics solution, to elevate its precision medicine program.
As a dynamic health system with 25 locations, Frederick Health is dedicated to delivering a range of healthcare and wellness services. With a team of over 4,000 team members, Frederick Health is steadfast in its mission to positively impact the well-being of every individual in their community.
“We continue to enhance our Precision Medicine & Genetics program through Expanse Genomics and now our partnership with GenomOncology’s platform, including treatment options with clinical trials and approved therapies. This capability is a differentiator in the healthcare market and allows us to continue our mission to positively impact the well-being of every individual in our community,” said Jackie Rice, Vice President and Chief Information Officer with Frederick Health.
To augment their program offerings and better cater to their community’s needs, Frederick Health has successfully implemented Expanse Genomics as part of its MEDITECH Expanse Electronic Health Record (EHR). This strategic integration empowers Frederick Health’s healthcare professionals to order genetic tests, analyze discrete results, and guide effective treatments based on specific genetic profiles, directly inside their Expanse EHR.
“This groundbreaking, first-of-its-kind solution marries the vast amount of data in the EHR, allowing organizations such as Frederick Health to view and act upon specifically matched therapies and clinical trials right within their everyday EHR workflow,” says Jennifer Ford, MEDITECH’s Manager of Product Management. “The advent of true precision medicine within the EHR promises to change the way oncologists treat patients today and in the future, and promises better patient outcomes.”
In order to further advance the capabilities of Expanse’s precision medicine offering, Frederick Health also leveraged GenomOncology’s Precision Oncology Platform within Expanse Genomics. Enabled via the GenomOncology Precision Oncology API Suite and a seamless integration developed by MEDITECH and GenomOncology, the Frederick Health team has expanded access to comprehensive precision medicine information within the EHR, bolstering their overall decision support capabilities.
GenomOncology’s Precision Oncology Platform harmonizes the latest precision oncology insights, encompassing a rich set of annotations, ontologies, and curated content from public, licensed, and proprietary sources. With the GenomOncology Precision Oncology Platform, Frederick Health has access to meticulously curated precision oncology information, including clinical trials and approved therapies, enabling their team to make more informed recommendations for patients in a more time-efficient manner.
Bryan Storch, Vice President of Client Services at GenomOncology, highlighted the significance of the partnership, stating, “Our collaboration with Frederick Health opens up new avenues for delivering precision oncology care. The depth of information within the GenomOncology Precision Oncology Platform, coupled with the capabilities and expertise of the MEDITECH Expanse Genomics solution, empowers Frederick Health clinicians and researchers with the knowledge necessary to guide their patients’ overall treatment opportunities.”